These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
253 related items for PubMed ID: 15333338
1. Evaluation of patients referred for percutaneous ablation of renal tumors: importance of a preprocedural diagnosis. Tuncali K, vanSonnenberg E, Shankar S, Mortele KJ, Cibas ES, Silverman SG. AJR Am J Roentgenol; 2004 Sep; 183(3):575-82. PubMed ID: 15333338 [Abstract] [Full Text] [Related]
2. Imaging-guided radiofrequency ablation of solid renal tumors. Farrell MA, Charboneau WJ, DiMarco DS, Chow GK, Zincke H, Callstrom MR, Lewis BD, Lee RA, Reading CC. AJR Am J Roentgenol; 2003 Jun; 180(6):1509-13. PubMed ID: 12760910 [Abstract] [Full Text] [Related]
12. Early experience with percutaneous radiofrequency ablation of small solid renal masses. Roy-Choudhury SH, Cast JE, Cooksey G, Puri S, Breen DJ. AJR Am J Roentgenol; 2003 Apr; 180(4):1055-61. PubMed ID: 12646454 [Abstract] [Full Text] [Related]
13. Percutaneous core biopsy of small renal mass lesions: a diagnostic tool to better stratify patients for surgical intervention. Menogue SR, O'Brien BA, Brown AL, Cohen RJ. BJU Int; 2013 Apr; 111(4 Pt B):E146-51. PubMed ID: 22805186 [Abstract] [Full Text] [Related]
14. A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy. Lane BR, Babineau D, Kattan MW, Novick AC, Gill IS, Zhou M, Weight CJ, Campbell SC. J Urol; 2007 Aug; 178(2):429-34. PubMed ID: 17561141 [Abstract] [Full Text] [Related]
15. Percutaneous CT-guided radiofrequency ablation of renal neoplasms: factors influencing success. Zagoria RJ, Hawkins AD, Clark PE, Hall MC, Matlaga BR, Dyer RB, Chen MY. AJR Am J Roentgenol; 2004 Jul; 183(1):201-7. PubMed ID: 15208139 [Abstract] [Full Text] [Related]
16. Percutaneous cryoablation of renal cell carcinoma guided by horizontal open magnetic resonance imaging. Miki K, Shimomura T, Yamada H, Kishimoto K, Ohishi Y, Harada J, Egawa S. Int J Urol; 2006 Jul; 13(7):880-4. PubMed ID: 16882047 [Abstract] [Full Text] [Related]
17. Imaging-guided percutaneous ablation of renal cell carcinoma: a primer of how we do it. Uppot RN, Silverman SG, Zagoria RJ, Tuncali K, Childs DD, Gervais DA. AJR Am J Roentgenol; 2009 Jun; 192(6):1558-70. PubMed ID: 19457819 [Abstract] [Full Text] [Related]
18. Trends in the incidence of benign pathological lesions at partial nephrectomy for presumed renal cell carcinoma in renal masses on preoperative computed tomography imaging: a single institute experience with 290 consecutive patients. Lee SH, Park SU, Rha KH, Choi YD, Hong SJ, Yang SC, Mah SY, Chung BH. Int J Urol; 2010 Jun; 17(6):512-6. PubMed ID: 20345432 [Abstract] [Full Text] [Related]
19. Benign lesions after partial nephrectomy for presumed renal cell carcinoma in masses 4 cm or less: prevalence and predictors in Korean patients. Jeon HG, Lee SR, Kim KH, Oh YT, Cho NH, Rha KH, Yang SC, Han WK. Urology; 2010 Sep; 76(3):574-9. PubMed ID: 20303148 [Abstract] [Full Text] [Related]
20. Percutaneous radiofrequency ablation of renal cell carcinomas in patients with solitary kidney: 6 years experience. Mylona S, Kokkinaki A, Pomoni M, Galani P, Ntai S, Thanos L. Eur J Radiol; 2009 Feb; 69(2):351-6. PubMed ID: 18313248 [Abstract] [Full Text] [Related] Page: [Next] [New Search]